Hammond Janet MJ - Insider Non-Derivative Transactions at Atea Pharmaceuticals, Inc. (AVIR) - (SEC)

Updated on January 3, 2026.

According to recent SEC insider information filed on Jan 31, 2025, Hammond Janet MJ's relationship to Atea Pharmaceuticals, Inc. (AVIR) is Officer (Chief Development Officer), and currently has 95,522 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other AVIR insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

Hammond Janet MJ - Insider Non-Derivative Transactions of AVIR Common Stock

Hammond Janet MJ - Insider Non-Derivative Transactions at AVIR

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Feb 1, 2025	F -- (Common Stock)	14134	3.06	81388
Feb 1, 2025	M -- (Common Stock)	46800	0	84272
Feb 1, 2025	Acquisition -- (Common Stock)	11250	0	95522
Feb 2, 2024	Sell -- (Common Stock)	14029	3.84	35362
Feb 1, 2024	M -- (Common Stock)	46800	0	49391